Eli Lilly and Company (LLY) Earnings History
Annual and quarterly earnings data from 1989 to 2024
Loading earnings history...
EPS Growth Rates (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 81.3% | 38.9% | 23.5% |
| 2023 | 79.2% | 31.6% | 15.4% |
| 2022 | 76.8% | 30.3% | 21.9% |
| 2021 | 74.2% | 28.0% | 19.7% |
| 2020 | 77.7% | 29.4% | 25.2% |
Download Data
Export LLY earnings history in CSV or JSON format
Free sign-in required to download data
Eli Lilly and Company (LLY) Earnings Overview
As of March 2, 2026, Eli Lilly and Company (LLY) reported trailing twelve-month net income of $18.41B, reflecting +1.0% year-over-year growth. The company earned $20.49 per diluted share over the past four quarters, with a net profit margin of 0.2%.
Looking at the long-term picture, LLY's 5-year EPS compound annual growth rate (CAGR) stands at +6.1%, showing solid earnings momentum. The company achieved its highest annual net income of $10.59B in fiscal 2024, representing a new all-time high.
Eli Lilly and Company maintains positive profitability with a gross margin of 0.8%, operating margin of 0.4%, and net margin of 0.2%. The company continues to generate positive earnings from operations. View revenue history →
Compared to industry peers including JNJ ($25.12B net income, 0.2% margin), AZN ($10.22B net income, 0.2% margin), BMY ($6.04B net income, -0.2% margin), LLY has outperformed on profitability metrics. Compare LLY vs JNJ →
Peer Comparison
Earnings metrics vs industry competitors
Historical Data
36 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $10.59B | +102.1% | $17.50B | $11.71 | 23.5% | 38.9% |
| 2023 | $5.24B | -16.1% | $10.79B | $5.80 | 15.4% | 31.6% |
| 2022 | $6.24B | +11.9% | $8.65B | $6.57 | 21.9% | 30.3% |
| 2021 | $5.58B | -9.9% | $7.93B | $5.85 | 19.7% | 28.0% |
| 2020 | $6.19B | -25.5% | $7.21B | $6.47 | 25.2% | 29.4% |
| 2019 | $8.32B | +157.4% | $6.00B | $8.69 | 37.3% | 26.9% |
| 2018 | $3.23B | +1683.5% | $6.03B | $3.13 | 15.0% | 28.0% |
| 2017 | -$204M | -107.5% | $4.25B | $-0.19 | -1.0% | 21.3% |
| 2016 | $2.74B | +13.7% | $3.87B | $2.49 | 12.9% | 18.2% |
| 2015 | $2.41B | +0.7% | $3.59B | $2.18 | 12.1% | 18.0% |
See LLY's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LLY Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare LLY vs AGIO
See how LLY stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is LLY growing earnings?
LLY EPS of $20.49 reflects slowing growth at +1.0%, below the 5-year CAGR of +6.1%. TTM net income is $18.4B. Expansion rate has moderated.
What are LLY's profit margins?
Eli Lilly and Company net margin is +0.2%, with operating margin at +0.4%. Below-average margins reflect competitive or cost pressures.
How consistent are LLY's earnings?
LLY earnings data spans 1989-2024. The current earnings trend is +1.0% YoY. Historical data enables comparison across business cycles.